• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of cmrPermissionsJournals.ASM.orgJournalCMR ArticleJournal InfoAuthorsReviewers
Clin Microbiol Rev. Jul 1993; 6(3): 266–310.
PMCID: PMC358286

The Mycobacterium avium complex.

Abstract

Mycobacterium avium complex (MAC) disease emerged early in the epidemic of AIDS as one of the common opportunistic infections afflicting human immunodeficiency virus-infected patients. However, only over the past few years has a consensus developed about its significance to the morbidity and mortality of AIDS. M. avium was well known to mycobacteriologists decades before AIDS, and the MAC was known to cause disease, albeit uncommon, in humans and animals. The early interest in the MAC provided a basis for an explosion of studies over the past 10 years largely in response to the role of the MAC in AIDS opportunistic infection. Molecular techniques have been applied to the epidemiology of MAC disease as well as to a better understanding of the genetics of antimicrobial resistance. The interaction of the MAC with the immune system is complex, and putative MAC virulence factors appear to have a direct effect on the components of cellular immunity, including the regulation of cytokine expression and function. There now is compelling evidence that disseminated MAC disease in humans contributes to both a decrease in the quality of life and survival. Disseminated disease most commonly develops late in the course of AIDS as the CD4 cells are depleted below a critical threshold, but new therapies for prophylaxis and treatment offer considerable promise. These new therapeutic modalities are likely to be useful in the treatment of other forms of MAC disease in patients without AIDS. The laboratory diagnosis of MAC disease has focused on the detection of mycobacteria in the blood and tissues, and although the existing methods are largely adequate, there is need for improvement. Indeed, the successful treatment of MAC disease clearly will require an early and rapid detection of the MAC in clinical specimens long before the establishment of the characteristic overwhelming infection of bone marrow, liver, spleen, and other tissue. Also, a standard method of susceptibility testing is of increasing interest and importance as new effective antimicrobial agents are identified and evaluated. Antimicrobial resistance has already emerged as an important problem, and methods for circumventing resistance that use combination therapies are now being studied.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (11M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abou-Zeid C, Ratliff TL, Wiker HG, Harboe M, Bennedsen J, Rook GA. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun. 1988 Dec;56(12):3046–3051. [PMC free article] [PubMed]
  • Adams LB, Franzblau SG, Vavrin Z, Hibbs JB, Jr, Krahenbuhl JL. L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J Immunol. 1991 Sep 1;147(5):1642–1646. [PubMed]
  • Adams LB, Hibbs JB, Jr, Taintor RR, Krahenbuhl JL. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol. 1990 Apr 1;144(7):2725–2729. [PubMed]
  • Agins BD, Berman DS, Spicehandler D, el-Sadr W, Simberkoff MS, Rahal JJ. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. J Infect Dis. 1989 Apr;159(4):784–787. [PubMed]
  • Agy MB, Wallis CK, Plorde JJ, Carlson LC, Coyle MB. Evaluation of four mycobacterial blood culture media: BACTEC 13A, Isolator/BACTEC 12B, Isolator/Middlebrook agar, and a biphasic medium. Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4):303–308. [PubMed]
  • Ahn CH, Ahn SS, Anderson RA, Murphy DT, Mammo A. A four-drug regimen for initial treatment of cavitary disease caused by Mycobacterium avium complex. Am Rev Respir Dis. 1986 Sep;134(3):438–441. [PubMed]
  • Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA. A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest. 1979 Feb;75(2):120–125. [PubMed]
  • Alessi DP, Dudley JP. Atypical mycobacteria-induced cervical adenitis. Treatment by needle aspiration. Arch Otolaryngol Head Neck Surg. 1988 Jun;114(6):664–666. [PubMed]
  • Arbeit RD, Slutsky A, Barber TW, Maslow JN, Niemczyk S, Falkinham JO, 3rd, O'Connor GT, von Reyn CF. Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS. J Infect Dis. 1993 Jun;167(6):1384–1390. [PubMed]
  • Armstrong D, Gold JW, Dryjanski J, Whimbey E, Polsky B, Hawkins C, Brown AE, Bernard E, Kiehn TE. Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Nov;103(5):738–743. [PubMed]
  • Bach MC. Treating disseminated Mycobacterium avium-intracellulare infection. Ann Intern Med. 1989 Jan 15;110(2):169–170. [PubMed]
  • Bach MC, Bagwell SP, Masur H. Utility of gallium imaging in the diagnosis of Mycobacterium avium-intracellulare infection in patients with the acquired immunodeficiency syndrome. Clin Nucl Med. 1986 Mar;11(3):175–177. [PubMed]
  • Baess I. Deoxyribonucleic acid relationships between different serovars of Mycobacterium avium, Mycobacterium intracellulare and Mycobacterium scrofulaceum. Acta Pathol Microbiol Immunol Scand B. 1983 Jun;91(3):201–203. [PubMed]
  • Barbaro DJ, Orcutt VL, Coldiron BM. Mycobacterium avium-Mycobacterium intracellulare infection limited to the skin and lymph nodes in patients with AIDS. Rev Infect Dis. 1989 Jul-Aug;11(4):625–628. [PubMed]
  • Barrow WW, Brennan PJ. Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens. J Bacteriol. 1982 Apr;150(1):381–384. [PMC free article] [PubMed]
  • Belisle JT, Pascopella L, Inamine JM, Brennan PJ, Jacobs WR., Jr Isolation and expression of a gene cluster responsible for biosynthesis of the glycopeptidolipid antigens of Mycobacterium avium. J Bacteriol. 1991 Nov;173(21):6991–6997. [PMC free article] [PubMed]
  • Bender BL, Yunis EJ. Disseminated nongranulomatous Mycobacterium avium osteomyelitis. Hum Pathol. 1980 Sep;11(5):476–478. [PubMed]
  • Benjamin DR. Granulomatous lymphadenitis in children. Arch Pathol Lab Med. 1987 Aug;111(8):750–753. [PubMed]
  • Bennett C, Vardiman J, Golomb H. Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med. 1986 May;80(5):891–896. [PubMed]
  • Berenbaum MC. A method for testing for synergy with any number of agents. J Infect Dis. 1978 Feb;137(2):122–130. [PubMed]
  • Berenbaum MC. Correlations between methods for measurement of synergy. J Infect Dis. 1980 Sep;142(3):476–480. [PubMed]
  • Bermudez LE. Infection of "nonprofessional phagocytes" with Mycobacterium avium complex. Clin Immunol Immunopathol. 1991 Nov;61(2 Pt 1):225–235. [PubMed]
  • Bermudez LE. Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin Exp Immunol. 1993 Feb;91(2):277–281. [PMC free article] [PubMed]
  • Bermudez LE. Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma. J Immunol. 1993 Mar 1;150(5):1838–1845. [PubMed]
  • Bermudez LE, Kolonoski P, Young LS. Natural killer cell activity and macrophage-dependent inhibition of growth or killing of Mycobacterium avium complex in a mouse model. J Leukoc Biol. 1990 Feb;47(2):135–141. [PubMed]
  • Bermudez LE, Petrofsky M, Kolonoski P, Young LS. An animal model of Mycobacterium avium complex disseminated infection after colonization of the intestinal tract. J Infect Dis. 1992 Jan;165(1):75–79. [PubMed]
  • Bermudez LE, Wu M, Enkel H, Young LS. Naturally occurring antibodies against Mycobacterium avium complex. Ann Clin Lab Sci. 1989 Nov-Dec;19(6):435–443. [PubMed]
  • Bermudez LE, Wu M, Martinelli J, Young LS. Ethanol affects release of TNF and GM-CSF and membrane expression of TNF receptors by human macrophages. Lymphokine Cytokine Res. 1991 Oct;10(5):413–419. [PubMed]
  • Bermudez LE, Wu M, Petrofsky M, Young LS. Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Infect Immun. 1992 Oct;60(10):4245–4252. [PMC free article] [PubMed]
  • Bermudez LE, Young LS. Phagocytosis and intracellular killing of Mycobacterium avium complex by human and murine macrophages. Braz J Med Biol Res. 1987;20(2):191–201. [PubMed]
  • Bermudez LE, Young LS. Oxidative and non-oxidative intracellular killing of Mycobacterium avium complex. Microb Pathog. 1989 Oct;7(4):289–298. [PubMed]
  • Bermudez LE, Young LS. Ethanol and survival of Mycobacterium avium complex within macrophages. Prog Clin Biol Res. 1990;325:383–391. [PubMed]
  • Bermudez LE, Young LS. Killing of Mycobacterium avium: insights provided by the use of recombinant cytokines. Res Microbiol. 1990 Feb;141(2):241–243. [PubMed]
  • Bermudez LE, Young LS. Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex. J Leukoc Biol. 1990 Jul;48(1):67–73. [PubMed]
  • Bermudez LE, Young LS. Ethanol augments intracellular survival of Mycobacterium avium complex and impairs macrophage responses to cytokines. J Infect Dis. 1991 Jun;163(6):1286–1292. [PubMed]
  • Bermudez LE, Young LS, Enkel H. Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins. Infect Immun. 1991 May;59(5):1697–1702. [PMC free article] [PubMed]
  • Bermudez LE, Young LS. Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. Antimicrob Agents Chemother. 1988 Aug;32(8):1149–1153. [PMC free article] [PubMed]
  • Bermudez LE, Young LS. Natural killer cell-dependent mycobacteriostatic and mycobactericidal activity in human macrophages. J Immunol. 1991 Jan 1;146(1):265–270. [PubMed]
  • Bermudez LE, Young LS. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol. 1988 May 1;140(9):3006–3013. [PubMed]
  • Bertram MA, Inderlied CB, Yadegar S, Kolanoski P, Yamada JK, Young LS. Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex. J Infect Dis. 1986 Jul;154(1):194–195. [PubMed]
  • Black CM, Bermudez LE, Young LS, Remington JS. Co-infection of macrophages modulates interferon gamma and tumor necrosis factor-induced activation against intracellular pathogens. J Exp Med. 1990 Sep 1;172(3):977–980. [PMC free article] [PubMed]
  • Blanchard DK, McMillen S, Hoffman SL, Djeu JY. Mycobacterial induction of activated killer cells: possible role of tyrosine kinase activity in interleukin-2 receptor alpha expression. Infect Immun. 1992 Jul;60(7):2843–2849. [PMC free article] [PubMed]
  • Blanchard DK, Michelini-Norris MB, Friedman H, Djeu JY. Lysis of mycobacteria-infected monocytes by IL-2-activated killer cells: role of LFA-1. Cell Immunol. 1989 Apr 1;119(2):402–411. [PubMed]
  • Blanchard DK, Michelini-Norris MB, Pearson CA, Freitag CS, Djeu JY. Mycobacterium avium-intracellulare induces interleukin-6 from human monocytes and large granular lymphocytes. Blood. 1991 May 15;77(10):2218–2224. [PubMed]
  • Blaser MJ, Cohn DL. Opportunistic infections in patients with AIDS: clues to the epidemiology of AIDS and the relative virulence of pathogens. Rev Infect Dis. 1986 Jan-Feb;8(1):21–30. [PubMed]
  • Blumenthal DR, Zucker JR, Hawkins CC. Mycobacterium avium complex-induced septic arthritis and osteomyelitis in a patient with the acquired immunodeficiency syndrome. Arthritis Rheum. 1990 May;33(5):757–758. [PubMed]
  • Böddinghaus B, Rogall T, Flohr T, Blöcker H, Böttger EC. Detection and identification of mycobacteria by amplification of rRNA. J Clin Microbiol. 1990 Aug;28(8):1751–1759. [PMC free article] [PubMed]
  • Bonavida B, Katz J, Gottlieb M. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2. J Immunol. 1986 Aug 15;137(4):1157–1163. [PubMed]
  • Böttger EC, Teske A, Kirschner P, Bost S, Chang HR, Beer V, Hirschel B. Disseminated "Mycobacterium genavense" infection in patients with AIDS. Lancet. 1992 Jul 11;340(8811):76–80. [PubMed]
  • Bouza E, Burgaleta C, Golde DW. Infections in hairy-cell leukemia. Blood. 1978 May;51(5):851–859. [PubMed]
  • Brennan PJ. Structures of the typing antigens of atypical mycobacteria: a brief review of present knowledge. Rev Infect Dis. 1981 Sep-Oct;3(5):905–913. [PubMed]
  • Brennan PJ. Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. Rev Infect Dis. 1989 Mar-Apr;11 (Suppl 2):S420–S430. [PubMed]
  • Brennan PJ, Aspinall GO, Shin JE. Structure of the specific oligosaccharides from the glycopeptidolipid antigens of serovars in the Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex. J Biol Chem. 1981 Jul 10;256(13):6817–6822. [PubMed]
  • Brennan PJ, Heifets M, Ullom BP. Thin-layer chromatography of lipid antigens as a means of identifying nontuberculous mycobacteria. J Clin Microbiol. 1982 Mar;15(3):447–455. [PMC free article] [PubMed]
  • Brooks RW, Parker BC, Gruft H, Falkinham JO., 3rd Epidemiology of infection by nontuberculous mycobacteria. V. Numbers in eastern United States soils and correlation with soil characteristics. Am Rev Respir Dis. 1984 Oct;130(4):630–633. [PubMed]
  • Brown ST, Edwards FF, Bernard EM, Niki Y, Armstrong D. Progressive disseminated infection with Mycobacterium avium complex after intravenous and oral challenge in cyclosporine-treated rats. J Infect Dis. 1991 Nov;164(5):922–927. [PubMed]
  • Brownback PE, Barrow WW. Modified lymphocyte response to mitogens after intraperitoneal injection of glycopeptidolipid antigens from Mycobacterium avium complex. Infect Immun. 1988 May;56(5):1044–1050. [PMC free article] [PubMed]
  • Camphausen RT, Jones RL, Brennan PJ. Antigenic relationship between Mycobacterium paratuberculosis and Mycobacterium avium. Am J Vet Res. 1988 Aug;49(8):1307–1310. [PubMed]
  • Cappell MS, Hassan T, Rosenthal S, Mascarenhas M. Gastrointestinal obstruction due to Mycobacterium avium intracellulare associated with the acquired immunodeficiency syndrome. Am J Gastroenterol. 1992 Dec;87(12):1823–1827. [PubMed]
  • Carson LA, Petersen NJ, Favero MS, Aguero SM. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol. 1978 Dec;36(6):839–846. [PMC free article] [PubMed]
  • Casal MJ, Rodriguez FC, Luna MD, Benavente MC. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium avium, Mycobacterium fortuitum, and Mycobacterium chelonae to ticarcillin in combination with clavulanic acid. Antimicrob Agents Chemother. 1987 Jan;31(1):132–133. [PMC free article] [PubMed]
  • Chaisson RE, Hopewell PC. Mycobacteria and AIDS mortality. Am Rev Respir Dis. 1989 Jan;139(1):1–3. [PubMed]
  • Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. Am Rev Respir Dis. 1992 Aug;146(2):285–289. [PubMed]
  • Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med. 1992 Apr 1;175(4):1111–1122. [PMC free article] [PubMed]
  • Chapman JS. The ecology of the atypicalmycobacteria. Arch Environ Health. 1971 Jan;22(1):41–46. [PubMed]
  • Chester AC, Winn WC., Jr Unusual and newly recognized patterns of nontuberculous mycobacterial infection with emphasis on the immunocompromised host. Pathol Annu. 1986;21(Pt 1):251–270. [PubMed]
  • Chiu J, Nussbaum J, Bozzette S, Tilles JG, Young LS, Leedom J, Heseltine PN, McCutchan JA. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group. Ann Intern Med. 1990 Sep 1;113(5):358–361. [PubMed]
  • Christensen EE, Dietz GW, Ahn CH, Chapman JS, Murry RC, Anderson J, Hurst GA. Pulmonary manifestations of Mycobacterium intracellularis. AJR Am J Roentgenol. 1979 Jul;133(1):59–66. [PubMed]
  • Clark R, Cardona L, Valainis G, Hanna B. Genitourinary infections caused by mycobacteria other than Mycobacterium tuberculosis. Tubercle. 1989 Dec;70(4):297–300. [PubMed]
  • Codias EK, Reinhardt DJ. Distribution of serotypes of the Mycobacterium avium-intracellulare-scrofulaceum complex in Georgia. Am Rev Respir Dis. 1979 Jun;119(6):965–970. [PubMed]
  • Coffin JW, Condon C, Compston CA, Potter KN, Lamontagne LR, Shafiq J, Kunimoto DY. Use of restriction fragment length polymorphisms resolved by pulsed-field gel electrophoresis for subspecies identification of mycobacteria in the Mycobacterium avium complex and for isolation of DNA probes. J Clin Microbiol. 1992 Jul;30(7):1829–1836. [PMC free article] [PubMed]
  • Cohen JI, Saragas SJ. Endophthalmitis due to Mycobacterium avium in a patient with AIDS. Ann Ophthalmol. 1990 Feb;22(2):47–51. [PubMed]
  • Coker RJ, Hellyer TJ, Brown IN, Weber JN. Clinical aspects of mycobacterial infections in HIV infection. Res Microbiol. 1992 May;143(4):377–381. [PubMed]
  • Cole GW, Gebhard J. Mycobacterium avium infection of the skin resembling lepromatous leprosy. Br J Dermatol. 1979 Jul;101(1):71–74. [PubMed]
  • Collert S, Petrini B, Wickman K. Osteomyelitis caused by Mycobacterium avium. Acta Orthop Scand. 1983 Jun;54(3):449–451. [PubMed]
  • Colley EW, Cox RA. Axillary lymphadenitis due to Mycobacterium avium-intracellulare. Postgrad Med J. 1983 Sep;59(695):588–589. [PMC free article] [PubMed]
  • Collins FM. Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence. Tubercle. 1985 Dec;66(4):267–276. [PubMed]
  • Collins FM. Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome. Clin Microbiol Rev. 1989 Oct;2(4):360–377. [PMC free article] [PubMed]
  • Collins FM, Stokes RW. Mycobacterium avium-complex infections in normal and immunodeficient mice. Tubercle. 1987 Jun;68(2):127–136. [PubMed]
  • Collins FM, Watson SR. Immune responses to atypical mycobacterial lung infections. Rev Infect Dis. 1981 Sep-Oct;3(5):981–989. [PubMed]
  • Contreras MA, Cheung OT, Sanders DE, Goldstein RS. Pulmonary infection with nontuberculous mycobacteria. Am Rev Respir Dis. 1988 Jan;137(1):149–152. [PubMed]
  • Corpe RF. Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare. Rev Infect Dis. 1981 Sep-Oct;3(5):1064–1067. [PubMed]
  • Coyle MB, Carlson LC, Wallis CK, Leonard RB, Raisys VA, Kilburn JO, Samadpour M, Böttger EC. Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients. J Clin Microbiol. 1992 Dec;30(12):3206–3212. [PMC free article] [PubMed]
  • Gangadharam PR, Edwards CK., 3rd Release of superoxide anion from resident and activated mouse peritoneal macrophages infected with Mycobacterium intracellulare. Am Rev Respir Dis. 1984 Nov;130(5):834–838. [PubMed]
  • Crawford JT, Bates JH. Phage typing of the Mycobacterium avium-intracellulare-scrofulaceum complex. A study of strains of diverse geographic and host origin. Am Rev Respir Dis. 1985 Aug;132(2):386–389. [PubMed]
  • Crawford JT, Bates JH. Analysis of plasmids in Mycobacterium avium-intracellulare isolates from persons with acquired immunodeficiency syndrome. Am Rev Respir Dis. 1986 Oct;134(4):659–661. [PubMed]
  • Crawford JT, Cave MD, Bates JH. Characterization of plasmids from strains of Mycobacterium avium-intracellulare. Rev Infect Dis. 1981 Sep-Oct;3(5):949–952. [PubMed]
  • Crawford JT, Cave MD, Bates JH. Evidence for plasmid-mediated restriction-modification in Mycobacterium avium intracellulare. J Gen Microbiol. 1981 Dec;127(2):333–338. [PubMed]
  • Crawford JT, Fitzhugh JK, Bates JH. Phage typing of the Mycobacterium avium-intracellulare-scrofulaceum complex. Am Rev Respir Dis. 1981 Nov;124(5):559–562. [PubMed]
  • Craythorn JM, Swartz M, Creel DJ. Clofazimine-induced bull's-eye retinopathy. Retina. 1986 Winter-Spring;6(1):50–52. [PubMed]
  • CROW HE, KING CT, SMITH CE, CORPE RF, STERGUS I. A limited clinical, pathologic, and epidemiologic study of patients with pulmonary lesions associated with atypical acid-fast bacilli in the sputum. Am Rev Tuberc. 1957 Feb;75(2):199–222. [PubMed]
  • Crowle AJ, Cohn DL, Poche P. Defects in sera from acquired immunodeficiency syndrome (AIDS) patients and from non-AIDS patients with Mycobacterium avium infection which decrease macrophage resistance to M. avium. Infect Immun. 1989 May;57(5):1445–1451. [PMC free article] [PubMed]
  • Crowle AJ, Dahl R, Ross E, May MH. Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic. Infect Immun. 1991 May;59(5):1823–1831. [PMC free article] [PubMed]
  • Crowle AJ, Tsang AY, Vatter AE, May MH. Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. J Clin Microbiol. 1986 Nov;24(5):812–821. [PMC free article] [PubMed]
  • Cynamon MH, Palmer GS, Sorg TB. Comparative in vitro activities of ampicillin, BMY 28142, and imipenem against Mycobacterium avium complex. Diagn Microbiol Infect Dis. 1987 Feb;6(2):151–155. [PubMed]
  • Cynamon MH, Swenson CE, Palmer GS, Ginsberg RS. Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice. Antimicrob Agents Chemother. 1989 Aug;33(8):1179–1183. [PMC free article] [PubMed]
  • D'Amato RF, Isenberg HD, Hochstein L, Mastellone AJ, Alperstein P. Evaluation of the Roche Septi-Chek AFB system for recovery of mycobacteria. J Clin Microbiol. 1991 Dec;29(12):2906–2908. [PMC free article] [PubMed]
  • Damsker B, Bottone EJ. Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: concepts regarding acquisition and pathogenesis. J Infect Dis. 1985 Jan;151(1):179–181. [PubMed]
  • Dautzenberg B, Saint Marc T, Meyohas MC, Eliaszewitch M, Haniez F, Rogues AM, De Wit S, Cotte L, Chauvin JP, Grosset J. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch Intern Med. 1993 Feb 8;153(3):368–372. [PubMed]
  • Dautzenberg B, Truffot C, Legris S, Meyohas MC, Berlie HC, Mercat A, Chevret S, Grosset J. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):564–569. [PubMed]
  • David HL. Response of Mycobacteria to ultraviolet light radiation. Am Rev Respir Dis. 1973 Nov;108(5):1175–1185. [PubMed]
  • David HL. Basis for lack of drug susceptibility of atypical mycobacteria. Rev Infect Dis. 1981 Sep-Oct;3(5):878–884. [PubMed]
  • Dawson DJ. Infection with Mycobacterium avium complex in Australian patients with AIDS. Med J Aust. 1990 Oct 15;153(8):466–468. [PubMed]
  • Debrunner M, Salfinger M, Brändli O, von Graevenitz A. Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis. 1992 Aug;15(2):330–345. [PubMed]
  • de Lalla F, Maserati R, Scarpellini P, Marone P, Nicolin R, Caccamo F, Rigoli R. Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. Antimicrob Agents Chemother. 1992 Jul;36(7):1567–1569. [PMC free article] [PubMed]
  • de Lamballerie X, Zandotti C, Vignoli C, Bollet C, de Micco P. A one-step microbial DNA extraction method using "Chelex 100" suitable for gene amplification. Res Microbiol. 1992 Oct;143(8):785–790. [PubMed]
  • Denis M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol. 1991 Apr;49(4):380–387. [PubMed]
  • Denis M, Gregg EO. Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages. Immunology. 1990 Sep;71(1):139–141. [PMC free article] [PubMed]
  • De Paepe ME, Guerrieri C, Waxman M. Opportunistic infections of the testis in the acquired immunodeficiency syndrome. Mt Sinai J Med. 1990 Jan;57(1):25–29. [PubMed]
  • Drake TA, Herron RM, Jr, Hindler JA, Berlin OG, Bruckner DA. DNA probe reactivity of Mycobacterium avium complex isolates from patients without AIDS. Diagn Microbiol Infect Dis. 1988 Nov;11(3):125–128. [PubMed]
  • Dugdale DC, Stevens DL, Knight LL. Mycotic aneurysm and disseminated Mycobacterium avium-intracellulare infection in a patient with hairy cell leukemia. West J Med. 1989 Feb;150(2):207–208. [PMC free article] [PubMed]
  • du Moulin GC, Sherman IH, Hoaglin DC, Stottmeier KD. Mycobacterium avium complex, an emerging pathogen in Massachusetts. J Clin Microbiol. 1985 Jul;22(1):9–12. [PMC free article] [PubMed]
  • du Moulin GC, Stottmeier KD, Pelletier PA, Tsang AY, Hedley-Whyte J. Concentration of Mycobacterium avium by hospital hot water systems. JAMA. 1988 Sep 16;260(11):1599–1601. [PubMed]
  • Düzgüneş N, Perumal VK, Kesavalu L, Goldstein JA, Debs RJ, Gangadharam PR. Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. Antimicrob Agents Chemother. 1988 Sep;32(9):1404–1411. [PMC free article] [PubMed]
  • Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis. 1969 Apr;99(4 Suppl):1–132. [PubMed]
  • Eggelmeijer F, Kroon FP, Zeeman RJ, Dijkmans BA, van 't Wout JW. Tenosynovitis due to Mycobacterium avium-intracellulare: case report and a review of the literature. Clin Exp Rheumatol. 1992 Mar-Apr;10(2):169–171. [PubMed]
  • Ellner PD, Kiehn TE, Cammarata R, Hosmer M. Rapid detection and identification of pathogenic mycobacteria by combining radiometric and nucleic acid probe methods. J Clin Microbiol. 1988 Jul;26(7):1349–1352. [PMC free article] [PubMed]
  • Eng RH, Bishburg E, Smith SM, Mangia A. Diagnosis of Mycobacterium bacteremia in patients with acquired immunodeficiency syndrome by direct examination of blood films. J Clin Microbiol. 1989 Apr;27(4):768–769. [PMC free article] [PubMed]
  • Engbaek HC, Vergmann B, Bentzon MW. Lung disease caused by Mycobacterium avium/Mycobacterium intracellulare. An analysis of Danish patients during the period 1962-1976. Eur J Respir Dis. 1981;62(2):72–83. [PubMed]
  • Etzkorn ET, Aldarondo S, McAllister CK, Matthews J, Ognibene AJ. Medical therapy of Mycobacterium avium-intracellulare pulmonary disease. Am Rev Respir Dis. 1986 Sep;134(3):442–445. [PubMed]
  • Evans KD, Nakasone AS, Sutherland PA, de la Maza LM, Peterson EM. Identification of Mycobacterium tuberculosis and Mycobacterium avium-M. intracellulare directly from primary BACTEC cultures by using acridinium-ester-labeled DNA probes. J Clin Microbiol. 1992 Sep;30(9):2427–2431. [PMC free article] [PubMed]
  • Falk GA, Hadley SJ, Sharkey FE, Liss M, Muschenheim C. Mycobacterium avium infections in man. Am J Med. 1973 Jun;54(6):801–810. [PubMed]
  • Falkinham JO, 3rd, Parker BC, Gruft H. Epidemiology of infection by nontuberculous mycobacteria. I. Geographic distribution in the eastern United States. Am Rev Respir Dis. 1980 Jun;121(6):931–937. [PubMed]
  • Farhi DC, Mason UG, 3rd, Horsburgh CR., Jr The bone marrow in disseminated Mycobacterium avium-intracellulare infection. Am J Clin Pathol. 1985 Apr;83(4):463–468. [PubMed]
  • Farhi DC, Mason UG, 3rd, Horsburgh CR., Jr Pathologic findings in disseminated Mycobacterium avium-intracellulare infection. A report of 11 cases. Am J Clin Pathol. 1986 Jan;85(1):67–72. [PubMed]
  • Fernandes PB, Hardy DJ, McDaniel D, Hanson CW, Swanson RN. In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrob Agents Chemother. 1989 Sep;33(9):1531–1534. [PMC free article] [PubMed]
  • Finlay BB, Falkow S. Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication. Biochimie. 1988 Aug;70(8):1089–1099. [PubMed]
  • Franzblau SG, Takeda T, Nakamura M. Mycobacterial plasmids: screening and possible relationship to antibiotic resistance in Mycobacterium avium/Mycobacterium intracellulare. Microbiol Immunol. 1986;30(9):903–907. [PubMed]
  • Frehel C, Ryter A, Rastogi N, David H. The electron-transparent zone in phagocytized Mycobacterium avium and other mycobacteria: formation, persistence and role in bacterial survival. Ann Inst Pasteur Microbiol. 1986 Nov-Dec;137B(3):239–257. [PubMed]
  • Friedman BF, Edwards D, Kirkpatrick CH. Mycobacterium avium-intracellulare: cutaneous presentations of disseminated disease. Am J Med. 1988 Aug;85(2):257–263. [PubMed]
  • Fry KL, Meissner PS, Falkinham JO., 3rd Epidemiology of infection by nontuberculous mycobacteria. VI. Identification and use of epidemiologic markers for studies of Mycobacterium avium, M. intracellulare, and M. scrofulaceum. Am Rev Respir Dis. 1986 Jul;134(1):39–43. [PubMed]
  • Furney SK, Roberts AD, Orme IM. Effect of rifabutin on disseminated Mycobacterium avium infections in thymectomized, CD4 T-cell-deficient mice. Antimicrob Agents Chemother. 1990 Sep;34(9):1629–1632. [PMC free article] [PubMed]
  • Gangadharam PR, Edwards CK, 3rd, Murthy PS, Pratt PF. An acute infection model for Mycobacterium intracellulare disease using beige mice: preliminary results. Am Rev Respir Dis. 1983 May;127(5):648–649. [PubMed]
  • Gangadharam PR, Kesavalu L, Rao PN, Perumal VK, Iseman MD. Activity of amikacin against Mycobacterium avium complex under simulated in vivo conditions. Antimicrob Agents Chemother. 1988 Jun;32(6):886–889. [PMC free article] [PubMed]
  • Gangadharam PR, Perumal VK, Crawford JT, Bates JH. Association of plasmids and virulence of Mycobacterium avium complex. Am Rev Respir Dis. 1988 Jan;137(1):212–214. [PubMed]
  • Gangadharam PR, Candler ER. Activity of some antileprosy compounds against Mycobacterium intracellulare in vitro. Am Rev Respir Dis. 1977 Apr;115(4):705–708. [PubMed]
  • Gangadharam PR, Perumal VK, Podapati NR, Kesavalu L, Iseman MD. In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice. Antimicrob Agents Chemother. 1988 Sep;32(9):1400–1403. [PMC free article] [PubMed]
  • Gangadharam PR, Edwards CK., 3rd Release of superoxide anion from resident and activated mouse peritoneal macrophages infected with Mycobacterium intracellulare. Am Rev Respir Dis. 1984 Nov;130(5):834–838. [PubMed]
  • Garrelts JC. Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection. DICP. 1991 May;25(5):525–531. [PubMed]
  • Georghiou PR, Mollee TF, Tilse MH. Pasteurella multocida infection after a Tasmanian devil bite. Clin Infect Dis. 1992 Jun;14(6):1266–1267. [PubMed]
  • Ghossein RA, Ross DG, Salomon RN, Rabson AR. Rapid detection and species identification of mycobacteria in paraffin-embedded tissues by polymerase chain reaction. Diagn Mol Pathol. 1992 Sep;1(3):185–191. [PubMed]
  • Gill MJ, Fanning EA, Chomyc S. Childhood lymphadenitis in a harsh northern climate due to atypical mycobacteria. Scand J Infect Dis. 1987;19(1):77–83. [PubMed]
  • Gill VJ, Park CH, Stock F, Gosey LL, Witebsky FG, Masur H. Use of lysis-centrifugation (isolator) and radiometric (BACTEC) blood culture systems for the detection of mycobacteremia. J Clin Microbiol. 1985 Oct;22(4):543–546. [PMC free article] [PubMed]
  • Girard AE, Girard D, English AR, Gootz TD, Cimochowski CR, Faiella JA, Haskell SL, Retsema JA. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother. 1987 Dec;31(12):1948–1954. [PMC free article] [PubMed]
  • Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother. 1989 Mar;33(3):277–282. [PMC free article] [PubMed]
  • Glasgow BJ, Layfield LJ, Anders KH. Mycobacterium avium-intracellulare and adrenal insufficiency in AIDS. Hum Pathol. 1988 Feb;19(2):245–246. [PubMed]
  • Godwin JH, Stopeck A, Chang VT, Godwin TA. Mycobacteremia in acquired immune deficiency syndrome. Rapid diagnosis based on inclusions in the peripheral blood smear. Am J Clin Pathol. 1991 Mar;95(3):369–375. [PubMed]
  • Gomez J, Pohajdak B, O'Neill S, Wilkins J, Greenberg AH. Activation of rat and human alveolar macrophage intracellular microbicidal activity by a preformed LGL cytokine. J Immunol. 1985 Aug;135(2):1194–1200. [PubMed]
  • Gonzalez AH, Berlin OG, Bruckner DA. In-vitro activity of dapsone and two potentiators against Mycobacterium avium complex. J Antimicrob Chemother. 1989 Jul;24(1):19–22. [PubMed]
  • Gonzalez R, Hanna BA. Evaluation of Gen-Probe DNA hybridization systems for the identification of Mycobacterium tuberculosis and Mycobacterium avium-intracellulare. Diagn Microbiol Infect Dis. 1987 Oct;8(2):69–77. [PubMed]
  • Good RC. Opportunistic pathogens in the genus Mycobacterium. Annu Rev Microbiol. 1985;39:347–369. [PubMed]
  • Good RC, Snider DE., Jr Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis. 1982 Dec;146(6):829–833. [PubMed]
  • Goslee S, Wolinsky E. Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis. 1976 Mar;113(3):287–292. [PubMed]
  • Graham L, Jr, Warren NG, Tsang AY, Dalton HP. Mycobacterium avium complex pseudobacteriuria from a hospital water supply. J Clin Microbiol. 1988 May;26(5):1034–1036. [PMC free article] [PubMed]
  • Graham DY, Markesich DC, Yoshimura HH. Mycobacteria and inflammatory bowel disease. Results of culture. Gastroenterology. 1987 Feb;92(2):436–442. [PubMed]
  • Gray JR, Rabeneck L. Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients. Am J Gastroenterol. 1989 Dec;84(12):1521–1524. [PubMed]
  • Green SJ, Meltzer MS, Hibbs JB, Jr, Nacy CA. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol. 1990 Jan 1;144(1):278–283. [PubMed]
  • Gribetz AR, Damsker B, Bottone EJ, Kirschner PA, Teirstein AS. Solitary pulmonary nodules due to nontuberculous mycobacterial infection. Am J Med. 1981 Jan;70(1):39–43. [PubMed]
  • Grice K. Sarcoidosis and Mycobacterium avium-intracellulare cutaneous abscesses. Clin Exp Dermatol. 1983 May;8(3):323–327. [PubMed]
  • Gruft H, Katz J, Blanchard DC. Postulated source of Mycobacterium intracellulare (Battey) infection. Am J Epidemiol. 1975 Oct;102(4):311–318. [PubMed]
  • Guthertz LS, Damsker B, Bottone EJ, Ford EG, Midura TF, Janda JM. Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis. 1989 Dec;160(6):1037–1041. [PubMed]
  • Hallander HO, Dornbusch K, Gezelius L, Jacobson K, Karlsson I. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother. 1982 Nov;22(5):743–752. [PMC free article] [PubMed]
  • Hampson SJ, Portaels F, Thompson J, Green EP, Moss MT, Hermon-Taylor J, McFadden JJ. DNA probes demonstrate a single highly conserved strain of Mycobacterium avium infecting AIDS patients. Lancet. 1989 Jan 14;1(8629):65–68. [PubMed]
  • Hance AJ, Grandchamp B, Lévy-Frébault V, Lecossier D, Rauzier J, Bocart D, Gicquel B. Detection and identification of mycobacteria by amplification of mycobacterial DNA. Mol Microbiol. 1989 Jul;3(7):843–849. [PubMed]
  • Haregewoin A, Soman G, Hom RC, Finberg RW. Human gamma delta+ T cells respond to mycobacterial heat-shock protein. Nature. 1989 Jul 27;340(6231):309–312. [PubMed]
  • Harshan KV, Gangadharam PR. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect Immun. 1991 Aug;59(8):2818–2821. [PMC free article] [PubMed]
  • Havlir D, Kemper CA, Deresinski SC. Reproducibility of lysis-centrifugation cultures for quantification of Mycobacterium avium complex bacteremia. J Clin Microbiol. 1993 Jul;31(7):1794–1798. [PMC free article] [PubMed]
  • Hawkins CC, Gold JW, Whimbey E, Kiehn TE, Brannon P, Cammarata R, Brown AE, Armstrong D. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1986 Aug;105(2):184–188. [PubMed]
  • Heifets L. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs. Antimicrob Agents Chemother. 1988 Aug;32(8):1131–1136. [PMC free article] [PubMed]
  • Heifets L. Qualitative and quantitative drug-susceptibility tests in mycobacteriology. Am Rev Respir Dis. 1988 May;137(5):1217–1222. [PubMed]
  • Heifets LB, Iseman MD, Lindholm-Levy PJ. Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1986 Dec;30(6):927–932. [PMC free article] [PubMed]
  • Heifets L, Lindholm-Levy P. Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis. Antimicrob Agents Chemother. 1989 Aug;33(8):1298–1301. [PMC free article] [PubMed]
  • Heifets LB. Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare. Am Rev Respir Dis. 1982 Jan;125(1):43–48. [PubMed]
  • Heifets LB, Iseman MD. Determination of in vitro susceptibility of mycobacteria to ansamycin. Am Rev Respir Dis. 1985 Sep;132(3):710–711. [PubMed]
  • Heifets LB, Iseman MD. Choice of antimicrobial agents for M. avium disease based on quantitative tests of drug susceptibility. N Engl J Med. 1990 Aug 9;323(6):419–420. [PubMed]
  • Heifets LB, Iseman MD, Lindholm-Levy PJ. Combinations of rifampin or rifabutine plus ethambutol against Mycobacterium avium complex. Bactericidal synergistic, and bacteriostatic additive or synergistic effects. Am Rev Respir Dis. 1988 Mar;137(3):711–715. [PubMed]
  • Heifets LB, Lindholm-Levy PJ. MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis. Antimicrob Agents Chemother. 1990 May;34(5):770–774. [PMC free article] [PubMed]
  • Heifets LB, Lindholm-Levy PJ, Comstock RD. Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):856–858. [PubMed]
  • Heifets LB, Lindholm-Levy PJ, Iseman MD. Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis. Am Rev Respir Dis. 1988 Mar;137(3):719–721. [PubMed]
  • Helbert M, Robinson D, Buchanan D, Hellyer T, McCarthy M, Brown I, Pinching AJ, Mitchell DM. Mycobacterial infection in patients infected with the human immunodeficiency virus. Thorax. 1990 Jan;45(1):45–48. [PMC free article] [PubMed]
  • Hellyer TJ, Brown IN, Dale JW, Easmon CS. Plasmid analysis of Mycobacterium avium-intracellulare (MAI) isolated in the United Kingdom from patients with and without AIDS. J Med Microbiol. 1991 Apr;34(4):225–231. [PubMed]
  • Herrod HG, Rourk MH, Jr, Spock A. Pulmonary disease in children caused by nontuberculous mycobacteria. J Pediatr. 1979 Jun;94(6):915–917. [PubMed]
  • Hoffman GS, Myers RL, Stark FR, Thoen CO. Septic arthritis associated with mycobacterium avium: a case report and literature review. J Rheumatol. 1978 Summer;5(2):199–209. [PubMed]
  • Hoffner SE. Improved detection of Mycobacterium avium complex with the Bactec radiometric system. Diagn Microbiol Infect Dis. 1988 May;10(1):1–6. [PubMed]
  • Hoffner SE, Källenius G, Petrini B, Brennan PJ, Tsang AY. Serovars of Mycobacterium avium complex isolated from patients in Sweden. J Clin Microbiol. 1990 Jun;28(6):1105–1107. [PMC free article] [PubMed]
  • Hoffner SE, Kratz M, Olsson-Liljequist B, Svenson SB, Källenius G. In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex. J Antimicrob Chemother. 1989 Sep;24(3):317–324. [PubMed]
  • Hoffner SE, Svenson SB, Beezer AE. Microcalorimetric studies of the initial interaction between antimycobacterial drugs and Mycobacterium avium. J Antimicrob Chemother. 1990 Mar;25(3):353–359. [PubMed]
  • Hoffner SE, Svenson SB, Källenius G. Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium. Eur J Clin Microbiol. 1987 Oct;6(5):530–535. [PubMed]
  • Hooper LC, Barrow WW. Decreased mitogenic response of murine spleen cells following intraperitoneal injection of serovar-specific glycopeptidolipid antigens from the Mycobacterium avium complex. Adv Exp Med Biol. 1988;239:309–325. [PubMed]
  • Horsburgh CR., Jr Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med. 1991 May 9;324(19):1332–1338. [PubMed]
  • Horsburgh CR, Jr, Cohn DL, Roberts RB, Masur H, Miller RA, Tsang AY, Iseman MD. Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1986 Dec;30(6):955–957. [PMC free article] [PubMed]
  • Horsburgh CR, Jr, Havlik JA, Ellis DA, Kennedy E, Fann SA, Dubois RE, Thompson SE. Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):557–559. [PubMed]
  • Horsburgh CR, Jr, Mason UG, 3rd, Farhi DC, Iseman MD. Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature. Medicine (Baltimore) 1985 Jan;64(1):36–48. [PubMed]
  • Horsburgh CR, Jr, Metchock BG, McGowan JE, Jr, Thompson SE. Clinical implications of recovery of Mycobacterium avium complex from the stool or respiratory tract of HIV-infected individuals. AIDS. 1992 May;6(5):512–514. [PubMed]
  • Horsburgh CR, Jr, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis. 1989 Jan;139(1):4–7. [PubMed]
  • Hoy J, Mijch A, Sandland M, Grayson L, Lucas R, Dwyer B. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. J Infect Dis. 1990 Apr;161(4):801–805. [PubMed]
  • Hubbard RD, Flory CM, Collins FM. T-cell immune responses in Mycobacterium avium-infected mice. Infect Immun. 1992 Jan;60(1):150–153. [PMC free article] [PubMed]
  • Hudolin V. Tuberculosis and alcoholism. Ann N Y Acad Sci. 1975 Apr 25;252:353–364. [PubMed]
  • Hudson V, Cox F, Taylor L, Guill M, Wray B, Steele J. Pulmonary clofazimine crystals in a child with acquired immunodeficiency syndrome and disseminated Mycobacterium avium-intracellulare infection. Pediatr Infect Dis J. 1988 Dec;7(12):880–882. [PubMed]
  • Hunter AM, Campbell IA, Jenkins PA, Smith AP. Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex. Thorax. 1981 May;36(5):326–329. [PMC free article] [PubMed]
  • Ichiyama S, Shimokata K, Tsukamura M. The isolation of Mycobacterium avium complex from soil, water, and dusts. Microbiol Immunol. 1988;32(7):733–739. [PubMed]
  • Inderlied CB, Kemper CA. Disseminated Mycobacterium avium complex infection. AIDS Clin Rev. 1992:131–172. [PubMed]
  • Inderlied CB, Kolonoski PT, Wu M, Young LS. Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice. Antimicrob Agents Chemother. 1989 Feb;33(2):176–180. [PMC free article] [PubMed]
  • Inderlied CB, Kolonoski PT, Wu M, Young LS. In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex. J Infect Dis. 1989 May;159(5):994–997. [PubMed]
  • Inderlied CB, Young LS. Disseminated Mycobacterium avium complex infection. AIDS Clin Rev. 1990:165–191. [PubMed]
  • Inderlied CB, Young LS, Yamada JK. Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods. Antimicrob Agents Chemother. 1987 Nov;31(11):1697–1702. [PMC free article] [PubMed]
  • Isaac-Renton JL, Allen EA, Chao CW, Grzybowski S, Whittaker EI, Black WA. Isolation and geographic distribution of Mycobacterium other than M. tuberculosis in British Columbia, 1972-81. CMAJ. 1985 Sep 15;133(6):573–576. [PMC free article] [PubMed]
  • Isberg RR. Pathways for the penetration of enteroinvasive Yersinia into mammalian cells. Mol Biol Med. 1990 Feb;7(1):73–82. [PubMed]
  • Iseman MD. Mycobacterium avium complex and the normal host: the other side of the coin. N Engl J Med. 1989 Sep 28;321(13):896–898. [PubMed]
  • Iseman MD, Corpe RF, O'Brien RJ, Rosenzwieg DY, Wolinsky E. Disease due to Mycobacterium avium-intracellulare. Chest. 1985 Feb;87(2 Suppl):139S–149S. [PubMed]
  • Isenberg HD, D'Amato RF, Heifets L, Murray PR, Scardamaglia M, Jacobs MC, Alperstein P, Niles A. Collaborative feasibility study of a biphasic system (Roche Septi-Chek AFB) for rapid detection and isolation of mycobacteria. J Clin Microbiol. 1991 Aug;29(8):1719–1722. [PMC free article] [PubMed]
  • Jacobs WR, Jr, Kalpana GV, Cirillo JD, Pascopella L, Snapper SB, Udani RA, Jones W, Barletta RG, Bloom BR. Genetic systems for mycobacteria. Methods Enzymol. 1991;204:537–555. [PubMed]
  • Jacobson MA, Hopewell PC, Yajko DM, Hadley WK, Lazarus E, Mohanty PK, Modin GW, Feigal DW, Cusick PS, Sande MA. Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis. 1991 Nov;164(5):994–998. [PubMed]
  • Janis EM, Kaufmann SH, Schwartz RH, Pardoll DM. Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis. Science. 1989 May 12;244(4905):713–716. [PubMed]
  • Jenkin DJ, Dall G. Lesions of bone in disseminated infection due to the mycobacterium avium-intracellulare group. Report of a case. J Bone Joint Surg Br. 1975 Aug;57(3):373–375. [PubMed]
  • Jensen AG, Bennedsen J, Rosdahl VT. Plasmid profiles of mycobacterium avium/intracellulare isolated from patients with AIDS or cervical lymphadenitis and from environmental samples. Scand J Infect Dis. 1989;21(6):645–649. [PubMed]
  • Johnson JL, Shiratsuchi H, Toba H, Ellner JJ. Preservation of monocyte effector functions against Mycobacterium avium-M. intracellulare in patients with AIDS. Infect Immun. 1991 Oct;59(10):3639–3645. [PMC free article] [PubMed]
  • Joshi W, Davidson PM, Jones PG, Campbell PE, Roberton DM. Non-tuberculous mycobacterial lymphadenitis in children. Eur J Pediatr. 1989 Aug;148(8):751–754. [PubMed]
  • Jucker MT, Falkinham JO., 3rd Epidemiology of infection by nontuberculous mycobacteria IX. Evidence for two DNA homology groups among small plasmids in Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum. Am Rev Respir Dis. 1990 Oct;142(4):858–862. [PubMed]
  • Kahn SA, Saltzman BR, Klein RS, Mahadevia PS, Friedland GH, Brandt LJ. Hepatic disorders in the acquired immune deficiency syndrome: a clinical and pathological study. Am J Gastroenterol. 1986 Dec;81(12):1145–1148. [PubMed]
  • Källenius G, Koivula T, Rydgård KJ, Hoffner SE, Valentin A, Asjö B, Ljungh C, Sharma U, Svenson SB. Human immunodeficiency virus type 1 enhances intracellular growth of Mycobacterium avium in human macrophages. Infect Immun. 1992 Jun;60(6):2453–2458. [PMC free article] [PubMed]
  • Källenius G, Svenson SB, Hoffner SE. Ethambutol: a key for Mycobacterium avium complex chemotherapy? Am Rev Respir Dis. 1989 Jul;140(1):264–264. [PubMed]
  • Katila ML, Mattila J. Enhanced isolation of MOTT on egg media of low pH. APMIS. 1991 Sep;99(9):803–807. [PubMed]
  • Katz P, Yeager H, Jr, Whalen G, Evans M, Swartz RP, Roecklein J. Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes. J Clin Immunol. 1990 Jan;10(1):71–77. [PubMed]
  • Kaufmann SH, Flesch I. Function and antigen recognition pattern of L3T4+ T-cell clones from Mycobacterium tuberculosis-immune mice. Infect Immun. 1986 Nov;54(2):291–296. [PMC free article] [PubMed]
  • Kaufmann SH. Role of T-cell subsets in bacterial infections. Curr Opin Immunol. 1991 Aug;3(4):465–470. [PubMed]
  • Kaur I, Ram J, Kumar B, Kaur S, Sharma VK. Effect of clofazimine on eye in multibacillary leprosy. Indian J Lepr. 1990 Jan-Mar;62(1):87–90. [PubMed]
  • Kelsey DS, Chambers RT, Hudspeth AS. Nontuberculous mycobacterial infection presenting as a mediastinal mass. J Pediatr. 1981 Mar;98(3):431–432. [PubMed]
  • Kemper CA, Meng TC, Nussbaum J, Chiu J, Feigal DF, Bartok AE, Leedom JM, Tilles JG, Deresinski SC, McCutchan JA. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group. Ann Intern Med. 1992 Mar 15;116(6):466–472. [PubMed]
  • Kerlikowske KM, Katz MH. Mycobacterium avium complex and Mycobacterium tuberculosis in patients infected with the human immunodeficiency virus. West J Med. 1992 Aug;157(2):144–148. [PMC free article] [PubMed]
  • Kiehn TE, Cammarata R. Laboratory diagnosis of mycobacterial infections in patients with acquired immunodeficiency syndrome. J Clin Microbiol. 1986 Nov;24(5):708–711. [PMC free article] [PubMed]
  • Kiehn TE, Cammarata R. Comparative recoveries of Mycobacterium avium-M. intracellulare from isolator lysis-centrifugation and BACTEC 13A blood culture systems. J Clin Microbiol. 1988 Apr;26(4):760–761. [PMC free article] [PubMed]
  • Kiehn TE, Edwards FF, Brannon P, Tsang AY, Maio M, Gold JW, Whimbey E, Wong B, McClatchy JK, Armstrong D. Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol. 1985 Feb;21(2):168–173. [PMC free article] [PubMed]
  • Kilby JM, Gilligan PH, Yankaskas JR, Highsmith WE, Jr, Edwards LJ, Knowles MR. Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest. 1992 Jul;102(1):70–75. [PubMed]
  • Kinsella JP, Culver K, Jeffrey RB, Kaplan MJ, Grossman M. Extensive cervical lymphadenitis due to Mycobacterium avium-intracellulare. Pediatr Infect Dis J. 1987 Mar;6(3):289–291. [PubMed]
  • Kinsella JP, Grossman M, Black S. Otomastoiditis caused by Mycobacterium avium-intracellulare. Pediatr Infect Dis. 1986 Nov-Dec;5(6):704–706. [PubMed]
  • Kirihara JM, Hillier SL, Coyle MB. Improved detection times for Mycobacterium avium complex and Mycobacterium tuberculosis with the BACTEC radiometric system. J Clin Microbiol. 1985 Nov;22(5):841–845. [PMC free article] [PubMed]
  • Klatt EC, Jensen DF, Meyer PR. Pathology of Mycobacterium avium-intracellulare infection in acquired immunodeficiency syndrome. Hum Pathol. 1987 Jul;18(7):709–714. [PubMed]
  • Knapp A, Stern GA, Hood CI. Mycobacterium avium-intracellulare corneal ulcer. Cornea. 1987;6(3):175–180. [PubMed]
  • Kuitert LM, Thomas MG, Ellis-Pegler RB. Outcome of untreated Mycobacterium avium-intracellulare complex infection in AIDS. AIDS. 1991 Aug;5(8):1036–1038. [PubMed]
  • Kunze ZM, Portaels F, McFadden JJ. Biologically distinct subtypes of Mycobacterium avium differ in possession of insertion sequence IS901. J Clin Microbiol. 1992 Sep;30(9):2366–2372. [PMC free article] [PubMed]
  • Kunze ZM, Wall S, Appelberg R, Silva MT, Portaels F, McFadden JJ. IS901, a new member of a widespread class of atypical insertion sequences, is associated with pathogenicity in Mycobacterium avium. Mol Microbiol. 1991 Sep;5(9):2265–2272. [PubMed]
  • Kurzrock R, Zander A, Vellekoop L, Kanojia M, Luna M, Dicke K. Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med. 1984 Jul;77(1):35–40. [PubMed]
  • Lai KK, Stottmeier KD, Sherman IH, McCabe WR. Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age. JAMA. 1984 Mar 9;251(10):1286–1288. [PubMed]
  • Lebrun L, Espinasse F, Poveda JD, Vincent-Levy-Frebault V. Evaluation of nonradioactive DNA probes for identification of mycobacteria. J Clin Microbiol. 1992 Sep;30(9):2476–2478. [PMC free article] [PubMed]
  • Lee BY, Chatterjee D, Bozic CM, Brennan PJ, Cohn DL, Bales JD, Harrison SM, Andron LA, Orme IM. Prevalence of serum antibody to the type-specific glycopeptidolipid antigens of Mycobacterium avium in human immunodeficiency virus-positive and -negative individuals. J Clin Microbiol. 1991 May;29(5):1026–1029. [PMC free article] [PubMed]
  • Levin RH, Bolinger AM. Treatment of nontuberculous mycobacterial infections in pediatric patients. Clin Pharm. 1988 Jul;7(7):545–551. [PubMed]
  • Levy H, Wayne LG, Anderson BE, Barnes PF, Light RW. Antimycobacterial antibody levels in pleural fluid as reflection of passive diffusion from serum. Chest. 1990 May;97(5):1144–1147. [PubMed]
  • Lévy-Frébault VV, Thorel MF, Varnerot A, Gicquel B. DNA polymorphism in Mycobacterium paratuberculosis, "wood pigeon mycobacteria," and related mycobacteria analyzed by field inversion gel electrophoresis. J Clin Microbiol. 1989 Dec;27(12):2823–2826. [PMC free article] [PubMed]
  • LEWIS AG, Jr, LASCHE EM, ARMSTRONG AL, DUNBAR FP. A clinical study of the chronic lung disease due to nonphotochromogenic acid-fast bacilli. Ann Intern Med. 1960 Aug;53:273–285. [PubMed]
  • Lewis LL, Butler KM, Husson RN, Mueller BU, Fowler CL, Steinberg SM, Pizzo PA. Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intracellulare infection. J Pediatr. 1992 Nov;121(5 Pt 1):677–683. [PubMed]
  • Leysen DC, Haemers A, Pattyn SR. Mycobacteria and the new quinolones. Antimicrob Agents Chemother. 1989 Jan;33(1):1–5. [PMC free article] [PubMed]
  • Lim SD, Todd J, Lopez J, Ford E, Janda JM. Genotypic identification of pathogenic Mycobacterium species by using a nonradioactive oligonucleotide probe. J Clin Microbiol. 1991 Jun;29(6):1276–1278. [PMC free article] [PubMed]
  • Lincoln EM, Gilbert LA. Disease in children due to mycobacteria other than Mycobacterium tuberculosis. Am Rev Respir Dis. 1972 May;105(5):683–714. [PubMed]
  • Lindholm-Levy PJ, Heifets LB. Clofazimine and other rimino-compounds: minimal inhibitory and minimal bactericidal concentrations at different pHs for Mycobacterium avium complex. Tubercle. 1988 Sep;69(3):179–186. [PubMed]
  • Love GL. Nontuberculous mycobacterial skin infection resembling lepromatous leprosy. South Med J. 1987 Aug;80(8):1060–1061. [PubMed]
  • Malhotra CM, Erickson AD, Feinsilver SH, Spraragen SC, McCully KS, Claunch BC. Ga-67 studies in a patient with acquired immunodeficiency syndrome and disseminated mycobacterial infection. Clin Nucl Med. 1985 Feb;10(2):96–98. [PubMed]
  • Mapother ME, Songer JG. In vitro interaction of Mycobacterium avium with intestinal epithelial cells. Infect Immun. 1984 Jul;45(1):67–73. [PMC free article] [PubMed]
  • Marchevsky A, Damsker B, Gribetz A, Tepper S, Geller SA. The spectrum of pathology of nontuberculous mycobacterial infections in open-lung biopsy specimens. Am J Clin Pathol. 1982 Nov;78(5):695–700. [PubMed]
  • Margileth AM. Management of nontuberculous (atypical) mycobacterial infections in children and adolescents. Pediatr Infect Dis. 1985 Mar-Apr;4(2):119–121. [PubMed]
  • Margileth AM, Chandra R, Altman RP. Chronic lymphadenopathy due to mycobacterial infection. Clinical features, diagnosis, histopathology, and management. Am J Dis Child. 1984 Oct;138(10):917–922. [PubMed]
  • Maricic MJ, Alepa FP. Reactive arthritis after Mycobacterium avium-intracellulare infection: Poncet's disease revisited. Am J Med. 1990 May;88(5):549–550. [PubMed]
  • Marinelli DL, Albelda SM, Williams TM, Kern JA, Iozzo RV, Miller WT. Nontuberculous mycobacterial infection in AIDS: clinical, pathologic, and radiographic features. Radiology. 1986 Jul;160(1):77–82. [PubMed]
  • Martin JL. Drinking patterns and drinking problems in a community sample of gay men. Prog Clin Biol Res. 1990;325:27–34. [PubMed]
  • Masaki S, Sugimori G, Okamoto A, Imose J, Hayashi Y. Effect of Tween 80 on the growth of Mycobacterium avium complex. Microbiol Immunol. 1990;34(8):653–663. [PubMed]
  • Masur H, Tuazon C, Gill V, Grimes G, Baird B, Fauci AS, Lane HC. Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. J Infect Dis. 1987 Jan;155(1):127–129. [PubMed]
  • Maurice PD, Bunker C, Giles F, Goldstone A, Holton J. Mycobacterium avium-intracellulare infection associated with hairy-cell leukemia. Arch Dermatol. 1988 Oct;124(10):1545–1549. [PubMed]
  • Mayer BK, Falkinham JO., 3rd Superoxide dismutase activity of Mycobacterium avium, M. intracellulare, and M. scrofulaceum. Infect Immun. 1986 Sep;53(3):631–635. [PMC free article] [PubMed]
  • Mazurek GH, Hartman S, Zhang Y, Brown BA, Hector JS, Murphy D, Wallace RJ., Jr Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool. J Clin Microbiol. 1993 Feb;31(2):390–394. [PMC free article] [PubMed]
  • McCarthy C. Effect of palmitic acid utilization on cell division in Mycobacterium avium. Infect Immun. 1974 Feb;9(2):363–372. [PMC free article] [PubMed]
  • McCarthy C. Synthesis and release of sulfolipid by Mycobacterium avium during growth andcell division. Infect Immun. 1976 Nov;14(5):1241–1252. [PMC free article] [PubMed]
  • McCarthy C. Ammonium ion requirement for the cell cycle of Mycobacterium avium. Infect Immun. 1978 Jan;19(1):304–311. [PMC free article] [PubMed]
  • McCarthy CM. Utilization of nitrate or nitrite as single nitrogen source by Mycobacterium avium. J Clin Microbiol. 1987 Feb;25(2):263–267. [PMC free article] [PubMed]
  • McCarthy C, Ashbaugh P. Factors that affect the cell cycle of Mycobacterium avium. Rev Infect Dis. 1981 Sep-Oct;3(5):914–925. [PubMed]
  • McFadden JJ, Butcher PD, Chiodini R, Hermon-Taylor J. Crohn's disease-isolated mycobacteria are identical to Mycobacterium paratuberculosis, as determined by DNA probes that distinguish between mycobacterial species. J Clin Microbiol. 1987 May;25(5):796–801. [PMC free article] [PubMed]
  • McFadden JJ, Kunze ZM, Portaels F, Labrousse V, Rastogi N. Epidemiological and genetic markers, virulence factors and intracellular growth of Mycobacterium avium in AIDS. Res Microbiol. 1992 May;143(4):423–436. [PubMed]
  • McNeil MR, Brennan PJ. Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information. Res Microbiol. 1991 May;142(4):451–463. [PubMed]
  • Mehle ME, Adamo JP, Mehta AC, Wiedemann HP, Keys T, Longworth DL. Endobronchial Mycobacterium avium-intracellulare infection in a patient with AIDS. Chest. 1989 Jul;96(1):199–201. [PubMed]
  • Meissner G, Anz W. Sources of Mycobacterium avium complex infection resulting in human diseases. Am Rev Respir Dis. 1977 Dec;116(6):1057–1064. [PubMed]
  • Mercier B, Gaucher C, Feugeas O, Mazurier C. Direct PCR from whole blood, without DNA extraction. Nucleic Acids Res. 1990 Oct 11;18(19):5908–5908. [PMC free article] [PubMed]
  • Meylan PR, Munis JR, Richman DD, Kornbluth RS. Concurrent human immunodeficiency virus and mycobacterial infection of macrophages in vitro does not reveal any reciprocal effect. J Infect Dis. 1992 Jan;165(1):80–86. [PubMed]
  • Meylan PR, Richman DD, Kornbluth RS. Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome. Infect Immun. 1990 Aug;58(8):2564–2568. [PMC free article] [PubMed]
  • Mikolich DJ, Mates SM. Granulomatous prostatitis due to Mycobacterium avium complex. Clin Infect Dis. 1992 Feb;14(2):589–591. [PubMed]
  • Miranda D, Vuletin JC, Kauffman SL. Disseminated histiocytosis and intestinal malakoplakia. Occurrence due to Mycobacterium intracellulare infection. Arch Pathol Lab Med. 1979 Jun;103(6):302–305. [PubMed]
  • Miyachi T, Shimokata K, Dawson DJ, Tsukamura M. Changes of the biotype of Mycobacterium avium-Mycobacterium intracellulare complex causing lung disease in Japan. Tubercle. 1988 Jun;69(2):133–137. [PubMed]
  • Mizuguchi Y, Fukunaga M, Taniguchi H. Plasmid deoxyribonucleic acid and translucent-to-opaque variation in Mycobacterium intracellulare 103. J Bacteriol. 1981 May;146(2):656–659. [PMC free article] [PubMed]
  • Mizuguchi Y, Ogawa M, Udou T. Morphological changes induced by beta-lactam antibiotics in Mycobacterium avium-intracellulare complex. Antimicrob Agents Chemother. 1985 Apr;27(4):541–547. [PMC free article] [PubMed]
  • Mizuguchi Y, Udou T, Yamada T. Mechanism of antibiotic resistance in Mycobacterium intracellulare. Microbiol Immunol. 1983;27(5):425–431. [PubMed]
  • Modilevsky T, Sattler FR, Barnes PF. Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med. 1989 Oct;149(10):2201–2205. [PubMed]
  • Morris SL, Bermudez L, Chaparas SD. Mycobacterium avium complex disease in patients with AIDS: seroreactivity to native and recombinant mycobacterial antigens. J Clin Microbiol. 1991 Dec;29(12):2715–2719. [PMC free article] [PubMed]
  • Morris SL, Rouse DA, Malik A, Chaparas SD, Witebsky FG. Characterisation of plasmids extracted from AIDS--associated Mycobacterium avium isolates. Tubercle. 1990 Sep;71(3):181–185. [PubMed]
  • Morrissey AB, Aisu TO, Falkinham JO, 3rd, Eriki PP, Ellner JJ, Daniel TM. Absence of Mycobacterium avium complex disease in patients with AIDS in Uganda. J Acquir Immune Defic Syndr. 1992;5(5):477–478. [PubMed]
  • Motyl MR, Saltzman B, Levi MH, McKitrick JC, Friedland GH, Klein RS. The recovery of Mycobacterium avium complex and Mycobacterium tuberculosis from blood specimens of AIDS patients using the nonradiometric BACTEC NR 660 medium. Am J Clin Pathol. 1990 Jul;94(1):84–86. [PubMed]
  • Mufarrij AA, Greco MA, Antopol SC, Borkowsky W. The histopathology of cervical lymphadenitis caused by Mycobacterium avium-Mycobacterium intracellulare complex in an immunocompromised host. Hum Pathol. 1982 Jan;13(1):78–81. [PubMed]
  • Murray HW, Scavuzzo DA, Chaparas SD, Roberts RB. T lymphocyte responses to mycobacterial antigen in AIDS patients with disseminated Mycobacterium avium-Mycobacterium intracellulare infection. Chest. 1988 May;93(5):922–925. [PubMed]
  • Musial CE, Tice LS, Stockman L, Roberts GD. Identification of mycobacteria from culture by using the Gen-Probe Rapid Diagnostic System for Mycobacterium avium complex and Mycobacterium tuberculosis complex. J Clin Microbiol. 1988 Oct;26(10):2120–2123. [PMC free article] [PubMed]
  • Naik S, Ruck R. In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. Antimicrob Agents Chemother. 1989 Sep;33(9):1614–1616. [PMC free article] [PubMed]
  • Naik SP, Samsonoff WA, Ruck RE. Effects of surface-active agents on drug susceptibility levels and ultrastructure of Mycobacterium avium complex organisms isolated from AIDS patients. Diagn Microbiol Infect Dis. 1988 Sep;11(1):11–19. [PubMed]
  • Nakamura RM, Goto Y, Kitamura K, Tokunaga T. Two types of suppressor T cells that inhibit delayed-type hypersensitivity to Mycobacterium intracellulare in mice. Infect Immun. 1989 Mar;57(3):779–784. [PMC free article] [PubMed]
  • Nassos PS, Yajko DM, Sanders CA, Hadley WK. Prevalence of Mycobacterium avium complex in respiratory specimens from AIDS and non-AIDS patients in a San Francisco hospital. Am Rev Respir Dis. 1991 Jan;143(1):66–68. [PubMed]
  • Nel EE. Mycobacterium avium-intracellulare complex serovars isolated in South Africa from humans, swine, and the environment. Rev Infect Dis. 1981 Sep-Oct;3(5):1013–1020. [PubMed]
  • Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne BA. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis. 1992 Jun;165(6):1082–1085. [PubMed]
  • Noel SB, Ray MC, Greer DL. Cutaneous infection with Mycobacterium avium-intracellulare scrofulaceum intermediate: a new pathogenic entity. J Am Acad Dermatol. 1988 Sep;19(3):492–495. [PubMed]
  • Nozawa RT, Kato H, Yokota T, Sugi H. Susceptibility of intra- and extracellular Mycobacterium avium-intracellulare to cephem antibiotics. Antimicrob Agents Chemother. 1985 Jan;27(1):132–134. [PMC free article] [PubMed]
  • Nuñez JM, Monteagudo I, López-Longo FJ, Cobeta JC, Rivera J. Disseminated Mycobacterium avium-intracellulare infection in a patient with polymyositis. Arthritis Rheum. 1989 Jul;32(7):934–936. [PubMed]
  • Nussbaum JM, Dealist C, Lewis W, Heseltine PN. Rapid diagnosis by buffy coat smear of disseminated Mycobacterium avium complex infection in patients with acquired immunodeficiency syndrome. J Clin Microbiol. 1990 Mar;28(3):631–632. [PMC free article] [PubMed]
  • Nyberg DA, Federle MP, Jeffrey RB, Bottles K, Wofsy CB. Abdominal CT findings of disseminated Mycobacterium avium-intracellulare in AIDS. AJR Am J Roentgenol. 1985 Aug;145(2):297–299. [PubMed]
  • O'Brien RJ, Geiter LJ, Lyle MA. Rifabutin (ansamycin LM427) for the treatment of pulmonary Mycobacterium avium complex. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):821–826. [PubMed]
  • O'Brien RJ, Geiter LJ, Snider DE., Jr The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis. 1987 May;135(5):1007–1014. [PubMed]
  • O'Brien RJ, Lyle MA, Snider DE., Jr Rifabutin (ansamycin LM 427): a new rifamycin-S derivative for the treatment of mycobacterial diseases. Rev Infect Dis. 1987 May-Jun;9(3):519–530. [PubMed]
  • O'Brien RL, Happ MP, Dallas A, Cranfill R, Hall L, Lang J, Fu YX, Kubo R, Born W. Recognition of a single hsp-60 epitope by an entire subset of gamma delta T lymphocytes. Immunol Rev. 1991 Jun;121:155–170. [PubMed]
  • O'Brien RL, Happ MP, Dallas A, Palmer E, Kubo R, Born WK. Stimulation of a major subset of lymphocytes expressing T cell receptor gamma delta by an antigen derived from Mycobacterium tuberculosis. Cell. 1989 May 19;57(4):667–674. [PubMed]
  • Orme IM, Collins FM. Immune response to atypical mycobacteria: immunocompetence of heavily infected mice measured in vivo fails to substantiate immunosuppression data obtained in vitro. Infect Immun. 1984 Jan;43(1):32–37. [PMC free article] [PubMed]
  • Orme IM, Collins FM. Prophylactic effect in mice of BCG vaccination against nontuberculous mycobacterial infections. Tubercle. 1985 Jun;66(2):117–120. [PubMed]
  • Orme IM, Stokes RW, Collins FM. Genetic control of natural resistance to nontuberculous mycobacterial infections in mice. Infect Immun. 1986 Oct;54(1):56–62. [PMC free article] [PubMed]
  • Ortbals DW, Marr JJ. A comparative study of tuberculous and other mycobacterial infections and their associations with malignancy. Am Rev Respir Dis. 1978 Jan;117(1):39–45. [PubMed]
  • Packer SJ, Cesario T, Williams JH., Jr Mycobacterium avium complex infection presenting as endobronchial lesions in immunosuppressed patients. Ann Intern Med. 1988 Sep 1;109(5):389–393. [PubMed]
  • Panaccio M, Lew A. PCR based diagnosis in the presence of 8% (v/v) blood. Nucleic Acids Res. 1991 Mar 11;19(5):1151–1151. [PMC free article] [PubMed]
  • Parker BC, Ford MA, Gruft H, Falkinham JO., 3rd Epidemiology of infection by nontuberculous mycobacteria. IV. Preferential aerosolization of Mycobacterium intracellulare from natural waters. Am Rev Respir Dis. 1983 Oct;128(4):652–656. [PubMed]
  • Pergament M, Gonzalez R, Fraley EE. Atypical mycobacteriosis of the urinary tract. A case report of extensive disease caused by the Battey bacillus. JAMA. 1974 Aug 12;229(7):816–817. [PubMed]
  • Perronne C, Gikas A, Truffot-Pernot C, Grosset J, Pocidalo JJ, Vilde JL. Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages. Antimicrob Agents Chemother. 1990 Aug;34(8):1508–1511. [PMC free article] [PubMed]
  • Perry RR, Jaques DP, Lesar MS, d'Avis JC, Peterson HD. Mycobacterium avium infection in a silicone-injected breast. Plast Reconstr Surg. 1985 Jan;75(1):104–106. [PubMed]
  • Peterson EM, Lu R, Floyd C, Nakasone A, Friedly G, de la Maza LM. Direct identification of Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium intracellulare from amplified primary cultures in BACTEC media using DNA probes. J Clin Microbiol. 1989 Jul;27(7):1543–1547. [PMC free article] [PubMed]
  • Peterson PK, Gekker G, Chao CC, Schut R, Verhoef J, Edelman CK, Erice A, Balfour HH., Jr Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures. J Immunol. 1992 Jul 15;149(2):676–680. [PubMed]
  • Pethel ML, Falkinham JO., 3rd Plasmid-influenced changes in Mycobacterium avium catalase activity. Infect Immun. 1989 Jun;57(6):1714–1718. [PMC free article] [PubMed]
  • Picken RN, Plotch SJ, Wang Z, Lin BC, Donegan JJ, Yang HL. DNA probes for mycobacteria. I. Isolation of DNA probes for the identification of Mycobacterium tuberculosis complex and for mycobacteria other than tuberculosis (MOTT). Mol Cell Probes. 1988 Jun;2(2):111–124. [PubMed]
  • Piscitelli SC, Danziger LH, Rodvold KA. Clarithromycin and azithromycin: new macrolide antibiotics. Clin Pharm. 1992 Feb;11(2):137–152. [PubMed]
  • Pitchenik AE, Cole C, Russell BW, Fischl MA, Spira TJ, Snider DE., Jr Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med. 1984 Nov;101(5):641–645. [PubMed]
  • Plikaytis BB, Plikaytis BD, Yakrus MA, Butler WR, Woodley CL, Silcox VA, Shinnick TM. Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol. 1992 Jul;30(7):1815–1822. [PMC free article] [PubMed]
  • Pohajdak B, Gomez JL, Wilkins JA, Greenberg AH. Tumor-activated NK cells trigger monocyte oxidative metabolism. J Immunol. 1984 Nov;133(5):2430–2436. [PubMed]
  • Poropatich CO, Labriola AM, Tuazon CU. Acid-fast smear and culture of respiratory secretions, bone marrow, and stools as predictors of disseminated Mycobacterium avium complex infection. J Clin Microbiol. 1987 May;25(5):929–930. [PMC free article] [PubMed]
  • Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med. 1989 Sep 28;321(13):863–868. [PubMed]
  • Pulliam JP, Vernon DD, Alexander SR, Hartstein AI, Golper TA. Nontuberculous mycobacterial peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1983 May;2(6):610–614. [PubMed]
  • Rastogi N, Frehel C, Ryter A, Ohayon H, Lesourd M, David HL. Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents? Antimicrob Agents Chemother. 1981 Nov;20(5):666–677. [PMC free article] [PubMed]
  • Rastogi N, Goh KS, David HL. Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis. Antimicrob Agents Chemother. 1990 May;34(5):759–764. [PMC free article] [PubMed]
  • Rastogi N, Hellio R, David HL. A new insight into the mycobacterial cell envelope architecture by the localization of antigens in ultrathin sections. Zentralbl Bakteriol. 1991 Aug;275(3):287–302. [PubMed]
  • Rastogi N, Labrousse V, Goh KS, De Sousa JP. Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages. Antimicrob Agents Chemother. 1991 Dec;35(12):2473–2480. [PMC free article] [PubMed]
  • Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest. 1992 Jun;101(6):1605–1609. [PubMed]
  • Reznikov M, Leggo JH, Dawson DJ. Investigation by seroagglutination of strains of the Mycobacterium intracellulare-M. scrofulaceum group from house dusts and sputum in Southeastern Queensland. Am Rev Respir Dis. 1971 Dec;104(6):951–953. [PubMed]
  • Rice L, Shenkenberg T, Lynch EC, Wheeler TM. Granulomatous infections complicating hairy cell leukemia. Cancer. 1982 May 1;49(9):1924–1928. [PubMed]
  • Riesbeck K, Andersson J, Gullberg M, Forsgren A. Fluorinated 4-quinolones induce hyperproduction of interleukin 2. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2809–2813. [PMC free article] [PubMed]
  • Rivoire B, Ranchoff BJ, Chatterjee D, Gaylord H, Tsang AY, Kolk AH, Aspinall GO, Brennan PJ. Generation of monoclonal antibodies to the specific sugar epitopes of Mycobacterium avium complex serovars. Infect Immun. 1989 Oct;57(10):3147–3158. [PMC free article] [PubMed]
  • Roberts MC, McMillan C, Coyle MB. Whole chromosomal DNA probes for rapid identification of Mycobacterium tuberculosis and Mycobacterium avium complex. J Clin Microbiol. 1987 Jul;25(7):1239–1243. [PMC free article] [PubMed]
  • Roecklein JA, Swartz RP, Yeager H., Jr Nonopsonic uptake of Mycobacterium avium complex by human monocytes and alveolar macrophages. J Lab Clin Med. 1992 Jun;119(6):772–781. [PubMed]
  • Rogers PL, Walker RE, Lane HC, Witebsky FG, Kovacs JA, Parrillo JE, Masur H. Disseminated Mycobacterium haemophilum infection in two patients with the acquired immunodeficiency syndrome. Am J Med. 1988 Mar;84(3 Pt 2):640–642. [PubMed]
  • Romanus V. Childhood tuberculosis in Sweden. An epidemiological study made six years after the cessation of general BCG vaccination of the newborn. Tubercle. 1983 Jun;64(2):101–110. [PubMed]
  • Rosenzweig DY, Schlueter DP. Spectrum of clinical disease in pulmonary infection with Mycobacterium avium-intracellulare. Rev Infect Dis. 1981 Sep-Oct;3(5):1046–1051. [PubMed]
  • Rotterdam H, Sommers SC. Alimentary tract biopsy lesions in the acquired immune deficiency syndrome. Pathology. 1985 Apr;17(2):181–192. [PubMed]
  • Rulong S, Aguas AP, da Silva PP, Silva MT. Intramacrophagic Mycobacterium avium bacilli are coated by a multiple lamellar structure: freeze fracture analysis of infected mouse liver. Infect Immun. 1991 Nov;59(11):3895–3902. [PMC free article] [PubMed]
  • Runyon EH. Ten mycobacterial pathogens. Tubercle. 1974 Sep;55(3):235–240. [PubMed]
  • Saito H, Sato K, Tomioka H. Comparative in vitro and in vivo activity of rifabutin and rifampicin against Mycobacterium avium complex. Tubercle. 1988 Sep;69(3):187–192. [PubMed]
  • Saito H, Tomioka H. Susceptibilities of transparent, opaque, and rough colonial variants of Mycobacterium avium complex to various fatty acids. Antimicrob Agents Chemother. 1988 Mar;32(3):400–402. [PMC free article] [PubMed]
  • Saito H, Tomioka H. Therapeutic efficacy of liposome-entrapped rifampin against Mycobacterium avium complex infection induced in mice. Antimicrob Agents Chemother. 1989 Apr;33(4):429–433. [PMC free article] [PubMed]
  • Saito H, Tomioka H, Sato K, Tasaka H, Dawson DJ. Identification of various serovar strains of Mycobacterium avium complex by using DNA probes specific for Mycobacterium avium and Mycobacterium intracellulare. J Clin Microbiol. 1990 Aug;28(8):1694–1697. [PMC free article] [PubMed]
  • Salfinger M, Stool EW, Piot D, Heifets L. Comparison of three methods for recovery of Mycobacterium avium complex from blood specimens. J Clin Microbiol. 1988 Jun;26(6):1225–1226. [PMC free article] [PubMed]
  • Sanderson TL, Moskowitz L, Hensley GT, Cleary TJ, Penneys N. Disseminated Mycobacterium avium-intracellulare infection appearing as a panniculitis. Arch Pathol Lab Med. 1982 Mar;106(3):112–114. [PubMed]
  • Sandler ED, Ng VL, Hadley WK. Clofazimine crystals in alveolar macrophages from a patient with the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1992 May;116(5):541–543. [PubMed]
  • Schaad UB, Votteler TP, McCracken GH, Jr, Nelson JD. Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr. 1979 Sep;95(3):356–360. [PubMed]
  • Schaad UB, Wedgwood J. Lack of quinolone-induced arthropathy in children. J Antimicrob Chemother. 1992 Oct;30(4):414–416. [PubMed]
  • Schaefer WB, Davis CL, Cohn ML. Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice. Am Rev Respir Dis. 1970 Oct;102(4):499–506. [PubMed]
  • Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol. 1990 Apr 1;144(7):2771–2780. [PubMed]
  • Schlesinger LS, Horwitz MA. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. J Clin Invest. 1990 Apr;85(4):1304–1314. [PMC free article] [PubMed]
  • Schuit KE, Hendley JO. Primary mycobacterial infection of the pharynx. Am J Dis Child. 1978 Feb;132(2):210–210. [PubMed]
  • Schurr E, Malo D, Radzioch D, Buschman E, Morgan K, Gros P, Skamene E. Genetic control of innate resistance to mycobacterial infections. Immunol Today. 1991 Mar;12(3):A42–A45. [PubMed]
  • Sherman I, Harrington N, Rothrock A, George H. Use of a cutoff range in identifying mycobacteria by the Gen-Probe Rapid Diagnostic System. J Clin Microbiol. 1989 Feb;27(2):241–244. [PMC free article] [PubMed]
  • Shiratsuchi H, Johnson JL, Ellner JJ. Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J Immunol. 1991 May 1;146(9):3165–3170. [PubMed]
  • Silva CL, Lukacs K, Lowrie DB. Major histocompatibility complex non-restricted presentation to CD4+ T lymphocytes of Mycobacterium leprae heat-shock protein 65 antigen by macrophages transfected with the mycobacterial gene. Immunology. 1993 Jan;78(1):35–42. [PMC free article] [PubMed]
  • Silva CL, Palacios A, Colston MJ, Lowrie DB. Mycobacterium leprae 65hsp antigen expressed from a retroviral vector in a macrophage cell line is presented to T cells in association with MHC class II in addition to MHC class I. Microb Pathog. 1992 Jan;12(1):27–38. [PubMed]
  • Simony N, Basset A, Ehrhardt JD, Porte A, Brini A. Pigmentation cornéo-conjonctivale au lamprène. Bull Mem Soc Fr Ophtalmol. 1986;97:215–217. [PubMed]
  • Simpson GL, Raffin TA, Remington JS. Association of prior nocardiosis and subsequent occurrence of nontuberculous mycobacteriosis in a defined, immunosuppressed population. J Infect Dis. 1982 Aug;146(2):211–219. [PubMed]
  • Skinner MH, Hsieh M, Torseth J, Pauloin D, Bhatia G, Harkonen S, Merigan TC, Blaschke TF. Pharmacokinetics of rifabutin. Antimicrob Agents Chemother. 1989 Aug;33(8):1237–1241. [PMC free article] [PubMed]
  • Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1991 Jan 31;324(5):289–294. [PubMed]
  • Snider DE, Jr, Jones WD, Good RC. The usefulness of phage typing Mycobacterium tuberculosis isolates. Am Rev Respir Dis. 1984 Dec;130(6):1095–1099. [PubMed]
  • Soini H, Skurnik M, Liippo K, Tala E, Viljanen MK. Detection and identification of mycobacteria by amplification of a segment of the gene coding for the 32-kilodalton protein. J Clin Microbiol. 1992 Aug;30(8):2025–2028. [PMC free article] [PubMed]
  • Songer JG. Environmental sources of Mycobacterium avium for infection of animals and man. Proc Annu Meet U S Anim Health Assoc. 1980;84:528–535. [PubMed]
  • Stacey AR. Isolation of Mycobacterium avium-intracellulare-scrofulaceum complex from faeces of patients with AIDS. Br Med J (Clin Res Ed) 1986 Nov 8;293(6556):1194–1194. [PMC free article] [PubMed]
  • Stahl DA, Urbance JW. The division between fast- and slow-growing species corresponds to natural relationships among the mycobacteria. J Bacteriol. 1990 Jan;172(1):116–124. [PMC free article] [PubMed]
  • Stanley MW, Horwitz CA, Burton LG, Weisser JA. Negative images of bacilli and mycobacterial infection: a study of fine-needle aspiration smears from lymph nodes in patients with AIDS. Diagn Cytopathol. 1990;6(2):118–121. [PubMed]
  • Stauffer F, Dörtbudak O, Lahonik E. In vitro testing of clarithromycin in combination with ethambutol and rifampicin against Mycobacterium avium complex. Infection. 1991 Sep-Oct;19(5):343–345. [PubMed]
  • Stewart DJ, Bodey GP. Infections in hairy cell leukemia (leukemic reticuloendotheliosis). Cancer. 1981 Feb 15;47(4):801–805. [PubMed]
  • Stone AB, Schelonka RL, Drehner DM, McMahon DP, Ascher DP. Disseminated Mycobacterium avium complex in non-human immunodeficiency virus-infected pediatric patients. Pediatr Infect Dis J. 1992 Nov;11(11):960–964. [PubMed]
  • Stormer RS, Falkinham JO., 3rd Differences in antimicrobial susceptibility of pigmented and unpigmented colonial variants of Mycobacterium avium. J Clin Microbiol. 1989 Nov;27(11):2459–2465. [PMC free article] [PubMed]
  • Strand CL, Epstein C, Verzosa S, Effatt E, Hormozi P, Siddiqi SH. Evaluation of a new blood culture medium for mycobacteria. Am J Clin Pathol. 1989 Mar;91(3):316–318. [PubMed]
  • Sutker WL, Lankford LL, Tompsett R. Granulomatous synovitis: the role of atypical mycobacteria. Rev Infect Dis. 1979 Sep-Oct;1(5):729–735. [PubMed]
  • Takashima T, Collins FM. T-cell-mediated immunity in persistent Mycobacterium intracellulare infections in mice. Infect Immun. 1988 Nov;56(11):2782–2787. [PMC free article] [PubMed]
  • Tassell SK, Pourshafie M, Wright EL, Richmond MG, Barrow WW. Modified lymphocyte response to mitogens induced by the lipopeptide fragment derived from Mycobacterium avium serovar-specific glycopeptidolipids. Infect Immun. 1992 Feb;60(2):706–711. [PMC free article] [PubMed]
  • Thoen CO, Karlson AG, Himes EM. Mycobacterial infections in animals. Rev Infect Dis. 1981 Sep-Oct;3(5):960–972. [PubMed]
  • Thorel MF, David HL. Specific surface antigens of SmT variants of Mycobacterium avium. Infect Immun. 1984 Jan;43(1):438–439. [PMC free article] [PubMed]
  • Thorel MF, Krichevsky M, Lévy-Frébault VV. Numerical taxonomy of mycobactin-dependent mycobacteria, emended description of Mycobacterium avium, and description of Mycobacterium avium subsp. avium subsp. nov., Mycobacterium avium subsp. paratuberculosis subsp. nov., and Mycobacterium avium subsp. silvaticum subsp. nov. Int J Syst Bacteriol. 1990 Jul;40(3):254–260. [PubMed]
  • TIMPE A, RUNYON EH. The relationship of atypical acid-fast bacteria to human disease; a preliminary report. J Lab Clin Med. 1954 Aug;44(2):202–209. [PubMed]
  • Tomioka H, Sato K, Saito H, Yamada Y. Susceptibility of Mycobacterium avium and Mycobacterium intracellulare to various antibacterial drugs. Microbiol Immunol. 1989;33(6):509–514. [PubMed]
  • Torres RA, Nord J, Feldman R, LaBombardi V, Barr M. Disseminated mixed Mycobacterium simiae-Mycobacterium avium complex infection in acquired immunodeficiency syndrome. J Infect Dis. 1991 Aug;164(2):432–433. [PubMed]
  • Tsukamura M, Miyachi T. Correlations among naturally occurring resistances to antituberculosis drugs in Mycobacterium avium complex strains. Am Rev Respir Dis. 1989 Apr;139(4):1033–1035. [PubMed]
  • Tsukamura M, Mizuno S, Murata H. Occurrence of Mycobacterium tuberculosis and strains of the Mycobacterium avium-M. intracellulare complex together in the sputum of patients with pulmonary tuberculosis. Tubercle. 1981 Mar;62(1):43–46. [PubMed]
  • Tsuyuguchi I, Shiratsuchi H, Okuda Y, Yamamoto Y. An analysis of in vitro T cell responsiveness in nontuberculous mycobacterial infection. Chest. 1988 Oct;94(4):822–829. [PubMed]
  • Tuffley RE, Holbeche JD. Isolation of the Mycobacterium avium-M. intracellulare-M. scrofulaceum complex from tank water in Queensland, Australia. Appl Environ Microbiol. 1980 Jan;39(1):48–53. [PMC free article] [PubMed]
  • Uldry PA, Bogousslavsky J, Regli F, Chave JP, Beer V. Chronic Mycobacterium avium complex infection of the central nervous system in a nonimmunosuppressed woman. Eur Neurol. 1992;32(5):285–288. [PubMed]
  • Uribe-Botero G, Prichard JG, Kaplowitz HJ. Bone marrow in HIV infection. A comparison of fluorescent staining and cultures in the detection of mycobacteria. Am J Clin Pathol. 1989 Mar;91(3):313–315. [PubMed]
  • Uyemura K, Deans RJ, Band H, Ohmen J, Panchamoorthy G, Morita CT, Rea TH, Modlin RL. Evidence for clonal selection of gamma/delta T cells in response to a human pathogen. J Exp Med. 1991 Sep 1;174(3):683–692. [PMC free article] [PubMed]
  • Vincent ME, Robbins AH. Mycobacterium avium-intracellulare complex enteritis: pseudo-Whipple disease in AIDS. AJR Am J Roentgenol. 1985 May;144(5):921–922. [PubMed]
  • von Reyn CF, Hennigan S, Niemczyk S, Jacobs NJ. Effect of delays in processing on the survival of Mycobacterium avium-M. intracellulare in the isolator blood culture system. J Clin Microbiol. 1991 Jun;29(6):1211–1214. [PMC free article] [PubMed]
  • Walker L, Lowrie DB. Killing of Mycobacterium microti by immunologically activated macrophages. Nature. 1981 Sep 3;293(5827):69–71. [PubMed]
  • Wallace JM, Hannah JB. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study. Chest. 1988 May;93(5):926–932. [PubMed]
  • Wallace RJ., Jr Nontuberculous mycobacteria and water: a love affair with increasing clinical importance. Infect Dis Clin North Am. 1987 Sep;1(3):677–686. [PubMed]
  • Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis. 1990 Oct;142(4):940–953. [PubMed]
  • Wardrop PA, Pillsbury HC., 3rd Mycobacterium avium acute mastoiditis. Arch Otolaryngol. 1984 Oct;110(10):686–687. [PubMed]
  • Wasem CF, McCarthy CM, Murray LW. Multilocus enzyme electrophoresis analysis of the Mycobacterium avium complex and other mycobacteria. J Clin Microbiol. 1991 Feb;29(2):264–271. [PMC free article] [PubMed]
  • Wayne LG. The "atypical" mycobacteria: recognition and disease association. Crit Rev Microbiol. 1985;12(3):185–222. [PubMed]
  • Wayne LG, Anderson B, Chetty K, Light RW. Antibodies to mycobacterial peptidoglycolipid and to crude protein antigens in sera from different categories of human subjects. J Clin Microbiol. 1988 Nov;26(11):2300–2306. [PMC free article] [PubMed]
  • Wayne LG, Good RC, Krichevsky MI, Blacklock Z, David HL, Dawson D, Gross W, Hawkins J, Levy-Frebault VV, McManus C, et al. Fourth report of the cooperative, open-ended study of slowly growing mycobacteria by the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol. 1991 Oct;41(4):463–472. [PubMed]
  • Wayne LG, Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev. 1992 Jan;5(1):1–25. [PMC free article] [PubMed]
  • Wayne LG, Young LS, Bertram M. Absence of mycobacterial antibody in patients with acquired immune deficiency syndrome. Eur J Clin Microbiol. 1986 Jun;5(3):363–365. [PubMed]
  • Weinstein RA, Golomb HM, Grumet G, Gelmann E, Schechter GP. Hairy cell leukemia: association with disseminated atypical mycobacterial infection. Cancer. 1981 Jul 15;48(2):380–383. [PubMed]
  • Wendt SL, George KL, Parker BC, Gruft H, Falkinham JO., 3rd Epidemiology of infection by nontuberculous Mycobacteria. III. Isolation of potentially pathogenic mycobacteria from aerosols. Am Rev Respir Dis. 1980 Aug;122(2):259–263. [PubMed]
  • Wiley EL, Mulhollan TJ, Beck B, Tyndall JA, Freeman RG. Polyclonal antibodies raised against Bacillus Calmette-Guerin, Mycobacterium duvalii, and Mycobacterium paratuberculosis used to detect mycobacteria in tissue with the use of immunohistochemical techniques. Am J Clin Pathol. 1990 Sep;94(3):307–312. [PubMed]
  • Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979 Jan;119(1):107–159. [PubMed]
  • Wolke A, Meyers S, Adelsberg BR, Bottone EJ, Damsker B, Schwartz IS, Janowitz HD. Mycobacterium avium-intracellulare-associated colitis in a patient with the acquired immunodeficiency syndrome. J Clin Gastroenterol. 1984 Jun;6(3):225–229. [PubMed]
  • Wong B, Edwards FF, Kiehn TE, Whimbey E, Donnelly H, Bernard EM, Gold JW, Armstrong D. Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am J Med. 1985 Jan;78(1):35–40. [PubMed]
  • Woodley CL, David HL. Effect of temperature on the rate of the transparent to opaque colony type transition in Mycobacterium avium. Antimicrob Agents Chemother. 1976 Jan;9(1):113–119. [PMC free article] [PubMed]
  • Woods GL, Washington JA., 2nd Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis. 1987 Mar-Apr;9(2):275–294. [PubMed]
  • Wright SD, Silverstein SC. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J Exp Med. 1983 Dec 1;158(6):2016–2023. [PMC free article] [PubMed]
  • Yagupsky P, Menegus MA. Cumulative positivity rates of multiple blood cultures for Mycobacterium avium-intracellulare and Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1990 Sep;114(9):923–925. [PubMed]
  • Yajko DM, Kirihara J, Sanders C, Nassos P, Hadley WK. Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome. Antimicrob Agents Chemother. 1988 Sep;32(9):1392–1395. [PMC free article] [PubMed]
  • Yajko DM, Nassos PS, Hadley WK. Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome. Antimicrob Agents Chemother. 1987 Oct;31(10):1579–1584. [PMC free article] [PubMed]
  • Yajko DM, Nassos PS, Hadley WK. Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents. Antimicrob Agents Chemother. 1987 Jan;31(1):117–120. [PMC free article] [PubMed]
  • Yajko DM, Nassos PS, Sanders CA, Gonzalez PC, Hadley WK. Comparison of the intracellular activities of clarithromycin and erythromycin against Mycobacterium avium complex strains in J774 cells and in alveolar macrophages from human immunodeficiency virus type 1-infected individuals. Antimicrob Agents Chemother. 1992 May;36(5):1163–1165. [PMC free article] [PubMed]
  • Yajko DM, Nassos PS, Sanders CA, Hadley WK. Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774. Am Rev Respir Dis. 1989 Nov;140(5):1198–1203. [PubMed]
  • Yakrus MA, Good RC. Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome. J Clin Microbiol. 1990 May;28(5):926–929. [PMC free article] [PubMed]
  • Yamori S, Tsukamura M. Paradoxical effect of Tween 80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfadimethoxine in the Mycobacterium avium-Mycobacterium intracellulare complex. Microbiol Immunol. 1991;35(10):921–926. [PubMed]
  • Yamori S, Tsukamura M. Comparison of prognosis of pulmonary diseases caused by Mycobacterium avium and by Mycobacterium intracellulare. Chest. 1992 Jul;102(1):89–90. [PubMed]
  • Yanagihara DL, Barr VL, Knisley CV, Tsang AY, McClatchy JK, Brennan PJ. Enzyme-linked immunosorbent assay of glycolipid antigens for identification of mycobacteria. J Clin Microbiol. 1985 Apr;21(4):569–574. [PMC free article] [PubMed]
  • Yoshimura HH, Graham DY. Nucleic acid hybridization studies of mycobactin-dependent mycobacteria. J Clin Microbiol. 1988 Jul;26(7):1309–1312. [PMC free article] [PubMed]
  • Young DB, Garbe TR. Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect Immun. 1991 Sep;59(9):3086–3093. [PMC free article] [PubMed]
  • Young LS. Mycobacterium avium complex infection. J Infect Dis. 1988 May;157(5):863–867. [PubMed]
  • Young LS, Berlin OG, Inderlied CB. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. Am J Med. 1987 Apr 27;82(4A):23–26. [PubMed]
  • Young LS, Inderlied CB, Berlin OG, Gottlieb MS. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis. 1986 Nov-Dec;8(6):1024–1033. [PubMed]
  • Young LS, Wiviott L, Wu M, Kolonoski P, Bolan R, Inderlied CB. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet. 1991 Nov 2;338(8775):1107–1109. [PubMed]
  • Zimmer BL, DeYoung DR, Roberts GD. In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex. Antimicrob Agents Chemother. 1982 Jul;22(1):148–150. [PMC free article] [PubMed]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...